BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 17304034)

  • 1. Diagnosis of polycystic ovary syndrome.
    Trivax B; Azziz R
    Clin Obstet Gynecol; 2007 Mar; 50(1):168-77. PubMed ID: 17304034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.
    Goodarzi MO; Azziz R
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):193-205. PubMed ID: 16772151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
    March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
    Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
    Carmina E; Azziz R
    Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.
    Kauffman RP; Baker TE; Baker VM; DiMarino P; Castracane VD
    Am J Obstet Gynecol; 2008 Jun; 198(6):670.e1-7; discussion 670.e7-10. PubMed ID: 18355776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions].
    Merino P; Schulin-Zeuthen C; Codner E
    Rev Med Chil; 2009 Aug; 137(8):1071-80. PubMed ID: 19915773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
    Hart R; Hickey M; Franks S
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult polycystic ovary syndrome begins in childhood.
    Franks S
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):263-72. PubMed ID: 12064892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome.
    Behera M; Price T; Walmer D
    Fertil Steril; 2006 Nov; 86(5):1292-5. PubMed ID: 17070182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome in adolescents.
    Franks S
    Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.
    Lowenstein EJ
    Dermatol Ther; 2006; 19(4):210-23. PubMed ID: 17004997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary forms of polycystic ovary syndrome.
    Kaltsas GA; Isidori AM; Besser GM; Grossman AB
    Trends Endocrinol Metab; 2004 Jul; 15(5):204-10. PubMed ID: 15223049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of androgen excess disorders.
    Carmina E
    Fertil Steril; 2006 Jun; 85(6):1582-5. PubMed ID: 16759919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L; Teede H
    Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reproductive phenotype in polycystic ovary syndrome.
    Chang RJ
    Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):688-95. PubMed ID: 17893687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.